|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2006-8-8
|
|
pubmed:abstractText |
Post-prandial lipid abnormalities might contribute to the excess of cardiovascular risk typical of type 2 diabetic patients. The study evaluated the effects of atorvastatin (20 mg d(-1)) vs. fenofibrate (200 mg d(-1)) on post-prandial lipids in type 2 diabetic patients with mixed hyperlipidaemia.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Fenofibrate,
http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Hypolipidemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, VLDL,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides,
http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0014-2972
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
560-5
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:16893378-Anticholesteremic Agents,
pubmed-meshheading:16893378-Area Under Curve,
pubmed-meshheading:16893378-Cholesterol,
pubmed-meshheading:16893378-Cholesterol, LDL,
pubmed-meshheading:16893378-Cross-Over Studies,
pubmed-meshheading:16893378-Diabetes Mellitus, Type 2,
pubmed-meshheading:16893378-Female,
pubmed-meshheading:16893378-Fenofibrate,
pubmed-meshheading:16893378-Heptanoic Acids,
pubmed-meshheading:16893378-Humans,
pubmed-meshheading:16893378-Hyperlipidemias,
pubmed-meshheading:16893378-Hypolipidemic Agents,
pubmed-meshheading:16893378-Lipoproteins, VLDL,
pubmed-meshheading:16893378-Male,
pubmed-meshheading:16893378-Middle Aged,
pubmed-meshheading:16893378-Postprandial Period,
pubmed-meshheading:16893378-Pyrroles,
pubmed-meshheading:16893378-Treatment Outcome,
pubmed-meshheading:16893378-Triglycerides
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
|
|
pubmed:affiliation |
Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
